Turtle Creek Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History
Turtle Creek Wealth Advisors, LLC
- $1.12 Trillion
- Q3 2025
A detailed history of Turtle Creek Wealth Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Turtle Creek Wealth Advisors, LLC holds 7,215 shares of GILD stock, worth $895,309. This represents 0.07% of its overall portfolio holdings.
Number of Shares
7,215
Previous 4,489
60.73%
Holding current value
$895,309
Previous $498 Million
60.93%
% of portfolio
0.07%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,366Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...